Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 3, 2001, Pages 810-814

  Auclair, B ^a   Nix, D E ^a   Adam, R D ^a   James, G T ^a   Peloquin, C A ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; ANTACID AGENT; CLOFAZIMINE; CYCLOSERINE; ETHIONAMIDE; MYLANTA; PYRIDOXINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; FEMALE; FOOD DRUG INTERACTION; FRUIT JUICE; GASTROINTESTINAL SYMPTOM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIPID DIET; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTACIDS; ANTITUBERCULAR AGENTS; CITRUS; CROSS-OVER STUDIES; DRUG INTERACTIONS; ETHIONAMIDE; FASTING; FEMALE; FOOD; HUMANS; MALE; THERAPEUTIC EQUIVALENCY;

EID: 0035115721     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.3.810-814.2001     Document Type: Article

References (28)

1. Treatment of tuberculosis infection in adults and children
2. Bioequivalence and bioequivalenee testing
3. Understanding bioequivalence testing
4. Bioequivalence and narrow therapeutic index drugs
5. Identification de trois nouveaux metabolites de l'ethionamide: Chromatographie, spectrophotometrie, polarographie
6. An approach for widening the bioequivalence acceptance limits in the case of highly variable drugs
7. Prediction of creatinine clearance from serum creatinine
8. Bioavailability and bioequivalence requirements
9. Blood ethionamide levels after administration of enteric-coated and uncoated tablets
10. High performance liquid chromatographic determination of ethionamide and prothionamide in body fluids
11. Plasma levels of ethionamide and prothionamide in a volunteer following intravenous and oral dosages
12. A comparison of the blood levels and urinary excretion of ethionamide and prothionamide in man
13. Gastro-intestinal side effects of clofazimine
14. Ethionamide and isoniazid in previously untreated cases of pulmonary tuberculosis
15. Logarithmic transformation in bioequivalence: Application with two formulations of perphenazine
16. Pharmacokinelics of pyrazinamide under fasting conditions, with food, and with antacids
17. Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids
18. Pharmacokinetic evaluation of ethionamide suppositories
19. Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids
20. Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids
21. Once-daily and twice-daily dosing of p-aminosalicylic acid granules
22. Side effects of clotazimine therapy
23. Comparison of ethionamide with isoniazid in original treatment cases of pulmonary, tuberculosis
24. Evaluation of orally administered highly variable drugs and drug formulations
25. Isoniazid and ethionamide serum levels and inactivation in Finnish subjects
26. High variability in drug pharmacokinetics complicates determination of bioequivalence: Experience with verapamil
27. The absorption and toxicity of ethionamide